A case of erythema elevatum diutinum with pyoderma gangrenosum

REFERENCES 1. Roizen NJ, Patterson D. Down's syndrome. Lancet. 2003; 361 (9365):1281– 9. https://doi.org/10.1016/S0140 6736 (03)12987 X 2. Ryan C, Vellody K, Belazarian L, Rork JF. Dermatologic conditions in Down syndrome. Pediatr Dermatol. 2021;38(Suppl 2):49– 57. https://doi.org/10.1111/pde.14731 3. Hao Y, Zhu YJ, Zou S, Zhou P, Hu YW, Zhao QX, et al. Metabolic syndrome and psoriasis: mechanisms and future directions. Front Immunol. 2021;12:711060. https://doi.org/10.3389/ fimmu.2021.711060 4. Versacci P, Di Carlo D, Digilio MC, Marino B. Cardiovascular disease in Down syndrome. Curr Opin Pediatr. 2018;30(5):616– 22. https://doi.org/10.1097/MOP.00000 00000 000661 5. SarziPuttini P, Atzeni F, Shoenfeld Y, Ferraccioli G. TNFalpha, rheumatoid arthritis, and heart failure: a rheumatological dilemma. Autoimmun Rev. 2005;4(3):153– 61. https://doi. org/10.1016/j.autrev.2004.09.004 6. Schepis C, Barone C, Siragusa M, Romano C. Prevalence of atopic dermatitis in patients with Down syndrome: a clinical survey. J Am Acad Dermatol. 1997;36(6 Pt 1):1019– 21. https:// doi.org/10.1016/s0190 9622(97)80294 0 7. Tancredi V, Licata G, Calabrese G, Gambardella A, De Rosa A, Alfano R, et al. Is itching in atopic dermatitis still an unmet need? A case series of 556 patients. J Eur Acad Dermatol Venereol. 2022;36(8):e650– 2. https://doi.org/10.1111/jdv. 18115 8. Dimitriou D, Halstead EJ. Sleeprelated learning in Williams Syndrome and Down's Syndrome. Adv Child Dev Behav. 2021;60:261– 83. https://doi.org/10.1016/bs.acdb. 2020.07.002

[1]  G. Argenziano,et al.  Is itching in atopic dermatitis still an unmet need? A case series of 556 patients , 2022, Journal of the European Academy of Dermatology and Venereology : JEADV.

[2]  Leah T. Belazarian,et al.  Dermatologic conditions in Down syndrome , 2021, Pediatric dermatology.

[3]  Jiong Li,et al.  Metabolic Syndrome and Psoriasis: Mechanisms and Future Directions , 2021, Frontiers in Immunology.

[4]  D. Dimitriou,et al.  Sleep-related learning in Williams Syndrome and Down's Syndrome. , 2021, Advances in child development and behavior.

[5]  M. van Egmond,et al.  IgA and FcαRI: Pathological Roles and Therapeutic Opportunities , 2019, Front. Immunol..

[6]  A. Mota,et al.  Pyoderma gangrenosum and erythema elevatum diutinum associated with a high-risk myelodysplastic syndrome: case report , 2018, Hematology, transfusion and cell therapy.

[7]  A. Bewley,et al.  Erythema elevatum diutinum–associated with loss of the uvula , 2017, JAAD case reports.

[8]  A. Sunandini,et al.  Erythema elevatum diutinum in association with IgA monoclonal gammopathy: A rare case report , 2016, Indian dermatology online journal.

[9]  O. Vanhooteghem,et al.  Associated pyoderma gangrenosum, erythema elevatum diutinum, and Sweet’s syndrome: the concept of neutrophilic disease , 2013, International journal of dermatology.

[10]  M. Bagot,et al.  [Erythema elevatum diutinum associated with pyoderma gangrenosum in an HIV-positive patient]. , 2010, Annales de dermatologie et de venereologie.

[11]  Y. Shoenfeld,et al.  TNF-alpha, rheumatoid arthritis, and heart failure: a rheumatological dilemma. , 2005, Autoimmunity reviews.

[12]  C. Romano,et al.  Prevalence of atopic dermatitis in patients with Down syndrome: a clinical survey. , 1997, Journal of the American Academy of Dermatology.

[13]  J. Wayte,et al.  Pyoderma gangrenosum, erythema elevatum diutinum and IgA monoclonal gammopathy , 1995, The Australasian journal of dermatology.

[14]  M. Johnson,et al.  Leukocyte colony-stimulating factors. A review of associated neutrophilic dermatoses and vasculitides. , 1994, Archives of dermatology.

[15]  R. Spicer,et al.  Cardiovascular disease in Down syndrome. , 1984, Pediatric clinics of North America.

[16]  E. Niebuhr,et al.  Down's syndrome , 1974, Humangenetik.